The 2017 Gastrointestinal Cancers Symposium will feature a wide array of multidisciplinary topics covering cancers of the esophagus and stomach, pancreas, small bowel and hepatobiliary tract, and the colon, rectum and anus.
Session topics include cutting-edge technologies for pancreatic cancer with discussion around stereotactic body radiation therapy from both the US and EU perspectives. Other topics include molecular subtypes in colorectal cancer, the role of molecular markers in clinical trials, and the immunotherapy of colorectal cancer.
Some sessions will use case-based discussions, with a range of subspecialties represented by the panelists. Topics for these sessions are: Multimodal Management of Esophageal Squamous Cell Carcinoma and Neuroendocrine Tumors—Practical Applications of Emerging Treatment Options. Subspecialties that are represented on these panels include medical oncologists, surgeons, radiation oncologists, interventional radiologist, endoscopists and nuclear medicine.
This year’s symposium will also include Keynote Lectures on each day on a variety of topics: Translational Research in Upper GI Cancers, The Promise of Biology in Advancing Early Diagnosis and Therapy, and The Emerging Role of the Gut Microbiome in Colorectal Cancer.